Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Theriogenology|October 3, 2008
Induction of abortion with aglepristone significantly changed the expression of progesterone and estrogen receptors in canine endometrial stromal cellsH Kanca, I Walter, S Schäfer-Somi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 1, 1993
Metabolism of benzbromarone in man: structures of new oxidative metabolites, 6-hydroxy- and 1'-oxo-benzbromarone, and the enantioselective formation and elimination of 1'-hydroxybenzbromaroneJ X De Vries, I Walter-Sack, A Voss, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|October 23, 2004
Endocrine disrupters in the aquatic environment: the Austrian approach--ARCEMW Bursch, M Fuerhacker, M Gemeiner, et al.
Reproduction in Domestic Animals = Zuchthygiene|September 17, 2009
Expression of MHC-I and -II in uterine tissue from early pregnant bitchesS Schäfer-Somi, H B Beceriklisoy, I Walter, et al.
Medical Oncology (Northwood, London, England)|November 4, 2017
Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trialI Walter, U Schulz, M Vogelhuber, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 3' end sequence of decay-accelerating factor's mRNAM L Tykocinski, H K Shu, D J Ayers, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Menin inhibition impairs metastatic colonization of Ewing sarcomaKatherine A Braun, Nicolas M Garcia, Mohamed Ahmed, et al.
Quality & Safety in Health Care|April 30, 2010
Patient-specific electronic decision support reduces prescription of excessive dosesH M Seidling, S P W Schmitt, T Bruckner, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 28, 1998
Relationship between hepatic cytochrome P450 3A content and activity and the disposition of midazolam administered orallyC Wandel, R H Böcker, H Böhrer, et al.
Investigative Ophthalmology & Visual Science|June 1, 1990
Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal glandJ H Lass, E I Walter, T E Burris, et al.
Pageof 20